119-3375

To require that the retail list price for certain prescription drugs and biological products may not exceed the average retail list price for the drug or biological product among certain nations.

Last action was on 5-13-2025

Bill is currently in: House
Path to Law
House Senate President

Current status is Referred to the House Committee on Energy and Commerce.

No users have voted for/against support on this bill yet. Be the first!

Detailed text is not currently available. Please wait for it to be uploaded by the United States Government.